Current Colorectal Cancer Reports

, Volume 4, Issue 1, pp 24–33

Noninvasive diagnostic modalities for early detection of colorectal cancer



Colorectal cancer (CRC) screening strategies currently approved are colonoscopy every 10 years, annual fecal occult blood testing (FOBT), flexible sigmoidoscopy every 5 years, annual FOBT plus flexible sigmoidoscopy, and double-contrast barium enema every 5 years. Colonoscopy has been shown to be preferable, but it is invasive, needs bowel preparation, entails a risk of perforation, and is highly operator-dependent. Several noninvasive strategies are being developed as alternatives to colonoscopy. CT colonography (CTC), also known as virtual colonoscopy, has widely variable results but has been shown to have acceptable cost-effectiveness at either 5-year or 10-year intervals, whether it is performed using two-dimensional or three-dimensional techniques. Fecal immunochemical tests have now been shown to have clearly superior performance compared with guaiac-based testing and may become the FOBT of choice. Stool DNA (sDNA) testing has been improved by the addition to the commercial assay of gel-based DNA capture and buffering solutions for DNA stabilization. Simplified sDNA assays (for vimentin methylation and long DNA only) may also improve sensitivity. Advances in our understanding of the molecular genetic changes involved in neoplastic transformation have led to new noninvasive methods to detect tumors. The future of CRC screening will be driven by the performance characteristics of these technologies, which will be more clearly understood as additional data emerge.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Regueiro CR: AGA Future Trends Committee report: colorectal cancer: a qualitative review of emerging screening and diagnostic technologies. Gastroenterology 2005, 129:1083–1103.PubMedCrossRefGoogle Scholar
  2. 2.
    McGregor SE, Hilsden RJ, Li FX, et al.: Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening. Am J Gastroenterol 2007, 102:1727–1735.PubMedCrossRefGoogle Scholar
  3. 3.
    Winaver S, Fletcher R, Rex D, et al.: Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology 2003, 124:544–560.CrossRefGoogle Scholar
  4. 4.
    Anderson WF, Guyton KZ, Hiatt RA, et al.: Colorectal cancer screening for persons at average risk. J Natl Cancer Inst 2002, 94:1126–1133.PubMedGoogle Scholar
  5. 5.
    Macari M: CT colonography: the real deal. Abdom Imaging 2005, 30:184–194.PubMedCrossRefGoogle Scholar
  6. 6.
    Frentz SM, Summers RM: Current status of CT colonography. Acad Radiol 2006, 13:1517–1531.PubMedCrossRefGoogle Scholar
  7. 7.
    Rockey DC: Colon imaging: computed tomographic colonography. Clin Gastroenterol Hepatol 2005, 3:S37–S41.PubMedCrossRefGoogle Scholar
  8. 8.
    Nicholson FB, Barro JL, Bartram CI, et al.: The role of CT colonography in colorectal cancer screening. Am J Gastroenterol 2005, 100:2315–2323.PubMedCrossRefGoogle Scholar
  9. 9.
    Burling D, Halligan S, Slater A, et al.: Potentially serious adverse events at CT colonography in symptomatic patients: national survey of the United Kingdom. Radiology 2006, 239:464–471.PubMedCrossRefGoogle Scholar
  10. 10.
    Wald C, Scheirey CD, Tran TM, Erbay N: An update on imaging of colorectal cancer. Surg Clin North Am 2006, 86:819–847.PubMedCrossRefGoogle Scholar
  11. 11.
    Dachman AH, Lefere P, Gryspeerdt S, Morin M: CT colonography: visualization methods, interpretation, and pitfalls. Radiol Clin North Am 2007, 45:347–359.PubMedCrossRefGoogle Scholar
  12. 12.
    Ferrucci JT: Colon cancer screening with virtual colonoscopy: promise, polyps, politics. AJR Am J Roentgenol 2001, 177:975–988.PubMedGoogle Scholar
  13. 13.
    Pickhardt PJ, Choi JR, Hwang I, et al.: Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003, 349:2191–2200.PubMedCrossRefGoogle Scholar
  14. 14.
    Cotton PB, Durkalski VL, Pineau BC, et al.: Computed tomographic colonography (virtual colonoscopy). A multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 2004, 291:1713–1719.PubMedCrossRefGoogle Scholar
  15. 15.
    Rockey DC, Paulson E, Niedzwiecki D, et al.: Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet 2005, 365:305–311.PubMedGoogle Scholar
  16. 16.
    Mulhall BP, Veerappan GR, Jackson JL: Meta-analysis: computed tomographic colonography. Ann Intern Med 2005, 142:635–650.PubMedGoogle Scholar
  17. 17.
    Halligan S, Altman DG, Taylor SA: CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology 2005, 237:893–904.PubMedCrossRefGoogle Scholar
  18. 18.
    Pickhardt PJ, Taylor AJ, Kim DH, et al.: Screening for colorectal neoplasia with CT colonography: initial experience from the 1st year of coverage by third-party payers. Radiology 2006, 241:417–425.PubMedCrossRefGoogle Scholar
  19. 19.
    Kim DH, Pickhardt PJ, Taylor AJ, et al.: CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med 2007, 357:1403–1412.PubMedCrossRefGoogle Scholar
  20. 20.
    Zalis ME, Barish MA, Choi JR, et al., for the Working Group on Virtual Colonoscopy: CT colonography reporting and data system: a consensus proposal. Radiology 2005, 236:3–9PubMedCrossRefGoogle Scholar
  21. 21.
    Rockey DC: Colon cancer screening, polyp size, and CT colonography: making sense of it all? Gastroenterology 2006, 131:2006–2009.PubMedCrossRefGoogle Scholar
  22. 22.
    Fidler, JL, Johnson, CD, MacCarty RL, et al.: Detection of flat lesions in the colon with CT colonography. Abdom Imaging 2002, 27:292–300.PubMedGoogle Scholar
  23. 23.
    Vijan S, Hwang I, Inadomi J, et al.: The cost-effectiveness of CT colonography in screening for colorectal neoplasia. Am J Gastroenterol 2007, 102:380–390.PubMedCrossRefGoogle Scholar
  24. 24.
    Callstrom MR, Johnson CD, Fletcher JG, et al.: CT colonography without cathartic preparation: feasibility study. Radiology 2001, 219:693–698.PubMedGoogle Scholar
  25. 25.
    Summers RM, Yao J, Pickhardt PJ, et al.: Computed tomographic virtual colonoscopy computer-aided polyp detection in a screening population. Gastroenterology 2005, 129:1832–1844.PubMedCrossRefGoogle Scholar
  26. 26.
    Kuehle CA, Langhorst, Ladd JSC, et al.: Magnetic resonance colonography without bowel cleansing: a prospective cross sectional study in a screening population. Gut 2007, 56:1079–1085.PubMedCrossRefGoogle Scholar
  27. 27.
    Rockey DC, Barish M, Brill JV: Standards for gastroenterologists for performing and interpreting diagnostic computed tomographic colonography. Gastroenterology 2007, 133:1005–1024.PubMedCrossRefGoogle Scholar
  28. 28.
    Young GP, St John DJB, Winawer SJ, et al.: Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 2002, 97:2499–2507.PubMedGoogle Scholar
  29. 29.
    Burke CA, Tadikonda L, Machicao V: Fecal occult blood testing for colorectal cancer screening: use the finger. Am J Gastroenterol 2001, 96:3175–3177.PubMedCrossRefGoogle Scholar
  30. 30.
    Levin B, Brooks D, Smith RA, Stone A: Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin 2003, 53:44–55.PubMedCrossRefGoogle Scholar
  31. 31.
    Segnan N, Senore C, Andreoni B, et al.: Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 2005, 97:347–357.PubMedGoogle Scholar
  32. 32.
    Church TR, Yeazel MW, Jones RM, et al.: A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst 2004, 96:770–780.PubMedGoogle Scholar
  33. 33.
    Towler B, Irwig L, Glasziou P, et al.: A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 1998, 317:559–565.PubMedGoogle Scholar
  34. 34.
    Moayyedi P, Achkar E: Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data. Am J Gastroenterol 2006, 101:380–384.PubMedCrossRefGoogle Scholar
  35. 35.
    Guittet L, Bouvier V, Mariotte N, et al.: Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007, 56:210–214.PubMedCrossRefGoogle Scholar
  36. 36.
    Morikawa T, Kato J, Yamaji Y, et al.: Comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005, 125:422–428.Google Scholar
  37. 37.
    Nakajima M, Saito H, Soma Y, et al.: Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: a cse-control study. Br J Cancer 2003, 89:23–28.PubMedCrossRefGoogle Scholar
  38. 38.
    Levi Z, Rozen P, Hazazi R, et al.: A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007, 146:244–255.PubMedGoogle Scholar
  39. 39.
    Morikawa T, Kato J, Yamaji Y, et al.: Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Am J Gastroenterol 2007, 102:1–6.CrossRefGoogle Scholar
  40. 40.
    Imperiale TF: Quantitative immunochemical fecal occult blood tests: Is it time to go back to the future? Ann Intern Med 2007, 146:309–311.PubMedGoogle Scholar
  41. 41.
    Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE: Noninvasive testing for colorectal cancer: a review. Am J Gastroenterol 2005, 100:1393–1403.PubMedCrossRefGoogle Scholar
  42. 42.
    Levin B: Molecular screening testing for colorectal cancer. Clin Cancer Res 2006, 12:5014–5017.PubMedCrossRefGoogle Scholar
  43. 43.
    Duffy MJ, van Dalen A, Haglund C, et al.: Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 2007, 43:1348–1360.PubMedCrossRefGoogle Scholar
  44. 44.
    Sidransky D, Tokino T, Hamilton SR, et al.: Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992, 256:102–105.PubMedCrossRefGoogle Scholar
  45. 45.
    Traverso G, Shuber A, Levin B, et al.: Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 2002, 346:311–320.PubMedCrossRefGoogle Scholar
  46. 46.
    Traverso G, Shuber A, Olsson L, et al.: Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet 2002, 359:403–404.PubMedCrossRefGoogle Scholar
  47. 47.
    Woolf SH: A smarter strategy? Reflections on fecal DNA screening for colorectal cancer. N Engl J Med 2004, 351:2755–2758.PubMedCrossRefGoogle Scholar
  48. 48.
    Chen WD, Han ZJ, Skoletsky J, et al.: Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005, 97:1124–1132.PubMedCrossRefGoogle Scholar
  49. 49.
    Ahlquist DA, Skoletsky JE, Boynton KA, et al.: Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000, 119:1219–1227.PubMedCrossRefGoogle Scholar
  50. 50.
    Imperiale TF, Ransohoff DF, Itzkowitz SH, et al.: Fecal DNA versus fecal occult blood for colorectal cancer screening in an average-risk population. N Engl J Med 2004, 351:2704–2714.PubMedCrossRefGoogle Scholar
  51. 51.
    Whitney D, Skoletsky J, Moore K, et al.: Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test. J Mol Diagn 2004, 6:386–395.PubMedGoogle Scholar
  52. 52.
    Itzkowitz SH, Jandorf L, Brand R, et al.: Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 2007, 5:111–117.PubMedCrossRefGoogle Scholar
  53. 53.
    Half EE, Lynch PM: Mutated DNA in the stool—Does it have a role in colorectal cancer screening? Nat Clin Pract Gastroenterol 2006, 3:594–595.CrossRefGoogle Scholar
  54. 54.
    Locker GY, Hamilton S, Harris J, et al.: ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006, 24:5313–5327.PubMedCrossRefGoogle Scholar
  55. 55.
    Diehl F, Li M, Dressman D, et al.: Detection and quantification of mutations in the plasma of patients with colorectal tumors. PNAS 2005, 102:16368–16373.PubMedCrossRefGoogle Scholar
  56. 56.
    Ward DG, Suggett N, Cheng Y, et al.: Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer 2006, 94:1898–1905.PubMedCrossRefGoogle Scholar
  57. 57.
    Habermann JK, Roblick UJ, Luke BT, et al.: Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors. Gastroenterology 2006, 131:1020–1029.PubMedCrossRefGoogle Scholar
  58. 58.
    Mandel JS, Bond JH, Church TR, et al.: Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993, 328:1365–1371.PubMedCrossRefGoogle Scholar
  59. 59.
    Kronborg O, Fenger C, Olsen J, et al.: Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348:1467–1471.PubMedCrossRefGoogle Scholar
  60. 60.
    Hardcastle JD, Chamberlain JO, Robinson MHE, et al.: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472–1477.PubMedCrossRefGoogle Scholar
  61. 61.
    Kewenter J, Brevinge H, Engaras B, et al.: Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 1994, 29:468–473.PubMedCrossRefGoogle Scholar
  62. 62.
    World Gastroenterology Organisation (WGO) Guidelines and Publications Committee and the International Digestive Cancer Alliance (IDCA): Practice guideline on colorectal cancer screening. Available at Accessed October 29, 2007.

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Instituto Aragonés de Ciencias de la SaludCIBERehdZaragozaSpain
  2. 2.Department of GastroenterologyHospital Clinico Universitario Lozano BlesaZaragozaSpain

Personalised recommendations